Global Water Purifier Market Analysis 2012-2016 & 2017-2022
Mar 05, 2018 15:41 pm UTC| Business
Dublin, March 05, 2018 -- The "Global Water Purifier Market: Analysis By Type, By End User, By Region, By Country (2018 Edition): Forecast to 2022 - By Region, By Country" report has been added to ...
Mar 05, 2018 15:33 pm UTC| Business
ARLINGTON, Va., March 05, 2018 -- South by Southwest® (SXSW®) has announced the addition of a panel discussion sponsored by LiveSafe - “Turning Tragedy into Action” - featuring LiveSafe co-founder and Virginia Tech...
Mar 05, 2018 15:32 pm UTC| Business
ARLINGTON, Va., March 05, 2018 -- South by Southwest® (SXSW®) Conference and Festivals has selected LiveSafe, the world’s leading mobile safety communications solution for use by staff and volunteers at SXSW 2018, March...
CUV Ventures Corp: Signs DA To Acquire Stake In Havana Consulting Group, Located In Florida USA
Mar 05, 2018 15:30 pm UTC| Business
VANCOUVER, British Columbia, March 05, 2018 -- CUV Ventures Corp. (TSX-V:CUV) (the “Company”) is pleased to announce that it has signed a definitive agreement to acquire a 10% minority stake in THCG AND TECH LLC...
Accellera Portable Test and Stimulus Early Adopter II Release Available for Public Review
Mar 05, 2018 15:30 pm UTC| Business
ELK GROVE, Calif., March 05, 2018 -- Accellera Systems Initiative (Accellera), the electronics industry organization focused on the creation and adoption of electronic design automation (EDA) and intellectual property...
Cruise Executives and Stakeholders Celebrate Launch of the FCCA’s Seatrade Cruise Global Events
Mar 05, 2018 15:29 pm UTC| Business
FORT LAUDERDALE, Fla., March 05, 2018 -- More than 200 cruise executives and key industry stakeholders gathered last night at Fort Lauderdale Boatyard to kick off a host of events coinciding with Seatrade Cruise Global...
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
Mar 05, 2018 15:23 pm UTC| Business
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation NDA acceptance of prucalopride reinforces Shire's long-standing heritage in gastrointestinal (GI) conditions and...